AAAAAA
Results:
1-13
|
Results: 13
Authors:
Lewis, EJ
Hunsicker, LG
Rodby, RA
Citation: Ej. Lewis et al., A clinical trial in type 2 diabetic nephropathy, AM J KIDNEY, 38(4), 2001, pp. S191-S194
Authors:
Cattran, DC
Appel, GB
Hebert, LA
Hunsicker, LG
Pohl, MA
Hoy, WE
Maxwell, DR
Kunis, CL
Citation: Dc. Cattran et al., Cyclosporine in patients with steroid-resistant membranous nephropathy: A randomized trial, KIDNEY INT, 59(4), 2001, pp. 1484-1490
Authors:
Lewis, EJ
Hunsicker, LG
Clarke, WR
Berl, T
Pohl, MA
Lewis, JB
Ritz, E
Atkins, RC
Rohde, R
Raz, I
Citation: Ej. Lewis et al., Renoprotective effect of the angiotensin-receptor antagonist irbesartan inpatients with nephropathy due to type 2 diabetes, N ENG J MED, 345(12), 2001, pp. 851-860
The Irbesartan Type II Diabetic Nephropathy Trial: study design and baseline patient characteristics
Authors:
Rodby, RA
Rohde, RD
Clarke, WR
Hunsicker, LG
Anzalone, DA
Atkins, RC
Ritz, E
Lewis, EJ
Citation: Ra. Rodby et al., The Irbesartan Type II Diabetic Nephropathy Trial: study design and baseline patient characteristics, NEPH DIAL T, 15(4), 2000, pp. 487-497
Authors:
Ernst, EJ
Klepser, ME
Klepser, TB
Nightingale, CH
Hunsicker, LG
Citation: Ej. Ernst et al., Comparison of the serum and intracellular pharmacokinetics of azithromycinin healthy and diabetic volunteers, PHARMACOTHE, 20(6), 2000, pp. 657-661
Authors:
Edwards, EB
Roberts, JP
Hunsicker, LG
Citation: Eb. Edwards et al., Volume of procedures at transplantation centers and mortality after liver transplantation - Reply, N ENG J MED, 342(20), 2000, pp. 1528-1528
Authors:
Levey, AS
Greene, T
Beck, GJ
Caggiula, AW
Kusek, JW
Hunsicker, LG
Klahr, S
Citation: As. Levey et al., Dietary protein restriction and the progression of chronic renal disease: What have all of the results of the MDRD study shown?, J AM S NEPH, 10(11), 1999, pp. 2426-2439
Authors:
Min, DI
Ku, YM
Rayhill, S
Corwin, C
Wu, YM
Hunsicker, LG
Citation: Di. Min et al., Sudden hearing loss associated with tacrolimus in a kidney-pancreas allograft recipient, PHARMACOTHE, 19(7), 1999, pp. 891-893
Authors:
Cattran, DC
Appel, GB
Hebert, LA
Hunsicker, LG
Pohl, MA
Hoy, WE
Maxwell, DR
Kunis, CL
Citation: Dc. Cattran et al., A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis, KIDNEY INT, 56(6), 1999, pp. 2220-2226
Authors:
Racusen, LC
Solez, K
Colvin, RB
Bonsib, SM
Castro, MC
Cavallo, T
Croker, BP
Demetris, AJ
Drachenberg, CB
Fogo, AB
Furness, P
Gaber, LW
Gibson, IW
Glotz, D
Goldberg, JC
Grande, J
Halloran, PF
Hansen, HE
Hartley, B
Hayry, PJ
Hill, CM
Hoffman, EO
Hunsicker, LG
Lindblad, AS
Marcussen, N
Mihatsch, MJ
Nadasdy, T
Nickerson, P
Olsen, TS
Papadimitriou, JC
Randhawa, PS
Rayner, DC
Roberts, I
Rose, S
Rush, D
Salinas-Madrigal, L
Salomon, DR
Sund, S
Taskinen, E
Trpkov, K
Yamaguchi, Y
Citation: Lc. Racusen et al., The Banff 97 working classification of renal allograft pathology, KIDNEY INT, 55(2), 1999, pp. 713-723
Authors:
Alexander, JW
Light, JA
Donaldson, LA
Delmonico, FL
Diethelm, AG
Wilkinson, A
Rosenthal, JT
Thistlethwaite, JR
Hunsicker, LG
Matas, AJ
First, MR
Reinsmoen, NL
Rose, SM
Citation: Jw. Alexander et al., Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients, TRANSPLANT, 68(8), 1999, pp. 1117-1124
Authors:
Edwards, EB
Roberts, JP
McBride, MA
Schulak, JA
Hunsicker, LG
Citation: Eb. Edwards et al., The effect of the volume of procedures at transplantation centers on mortality after liver transplantation., N ENG J MED, 341(27), 1999, pp. 2049-2053
Authors:
Hunsicker, LG
Citation: Lg. Hunsicker, A survival advantage for renal transplantation., N ENG J MED, 341(23), 1999, pp. 1762-1763
Risultati:
1-13
|